biote (BTMD) to Release Quarterly Earnings on Tuesday

biote (NASDAQ:BTMD) is expected to announce its earnings results after the market closes on Tuesday, March 11th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

biote Stock Performance

BTMD opened at $4.24 on Tuesday. biote has a one year low of $4.17 and a one year high of $8.44. The company has a market cap of $230.39 million, a P/E ratio of 16.31 and a beta of 1.04. The business’s 50-day simple moving average is $5.33 and its 200-day simple moving average is $5.67.

Wall Street Analyst Weigh In

Separately, Craig Hallum started coverage on biote in a research note on Monday, December 16th. They set a “buy” rating and a $12.00 price target on the stock.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.